Pharmaceuticals Direct
Pharmaceuticals Direct Ltd. (PDLUK) is a trusted pharmaceutical wholesaler established in 1999, specializing in the distribution, storage, and procurement of medicines and healthcare products. They are committed to delivering high-quality generic and branded medicines worldwide, offering comprehensive supply chain solutions including procurement, storage in MHRA-approved warehouses, and distribution services. PDLUK emphasizes compliance with GDP regulations, MHRA approval, and secure, traceable logistics. They also provide export services, dental supplies through DHB Oral Healthcare, and are actively involved in social values supporting community charities. Their mission is to streamline the pharmaceutical supply chain to ensure medicines are accessible and affordable globally, aiming to be a leader in innovative and ethical pharmaceutical supply chain solutions.
Industries
Nr. of Employees
medium (51-250)
Pharmaceuticals Direct
Products
Pharmaceutical product catalogue (medicines, vaccines, devices)
Extensive catalogue covering a wide range of medicinal and non-medicinal products including generics, branded medicines, vaccines and medical devices; maintained as a downloadable product list for wholesale customers.
Pharmaceutical product catalogue (medicines, vaccines, devices)
Extensive catalogue covering a wide range of medicinal and non-medicinal products including generics, branded medicines, vaccines and medical devices; maintained as a downloadable product list for wholesale customers.
Services
Temperature-controlled storage, pick & pack, scheduled and same-day delivery services from regulator-approved warehouse facilities.
Nationwide and international distribution using temperature-controlled vehicles and secure logistics to maintain product integrity during transit.
Sourcing of medicinal and non-medicinal products from an approved supplier network, including supplier validation and contract negotiation.
Support for international shipments including export documentation, customs clearance, market regulatory guidance and logistics coordination.
Provision of track-and-trace services and security protocols to provide real-time shipment visibility and tamper detection across the supply chain.
Guidance and documentation support to ensure compliance with GDP and national regulator requirements for wholesale distribution activities.
Temperature-controlled storage, pick & pack, scheduled and same-day delivery services from regulator-approved warehouse facilities.
Nationwide and international distribution using temperature-controlled vehicles and secure logistics to maintain product integrity during transit.
Sourcing of medicinal and non-medicinal products from an approved supplier network, including supplier validation and contract negotiation.
Support for international shipments including export documentation, customs clearance, market regulatory guidance and logistics coordination.
Provision of track-and-trace services and security protocols to provide real-time shipment visibility and tamper detection across the supply chain.
Guidance and documentation support to ensure compliance with GDP and national regulator requirements for wholesale distribution activities.
Expertise Areas
- Pharmaceutical distribution and cold chain logistics
- 3PL warehousing and fulfilment for healthcare products
- Regulatory compliance for wholesale distribution (GDP and national authorisations)
- International export and customs for pharmaceutical shipments
Key Technologies
- Cold chain logistics (refrigerated/ambient/frozen transport)
- Warehouse management systems (WMS) / resource management systems
- Track-and-trace / shipment traceability systems
- Real-time inventory and order management
News & Updates
The Proprietary Association of Great Britain (PAGB) recently hosted a landmark event in central London, gathering healthcare industry leaders to celebrate 40 years of medicines reclassification. The event highlighted a new collaboration between pharmaceutical companies, industry regulators, and pharmacy organizations aimed at accelerating the reclassification of prescription medicines to over-the-counter (OTC) status, thus improving patient access to treatments. The event underscored the transformative impact of reclassification on patient autonomy, allowing for more convenient access to effective medicines and enhancing self-care practices across the UK.
The Proprietary Association of Great Britain (PAGB) recently hosted a landmark event in central London, gathering healthcare industry leaders to celebrate 40 years of medicines reclassification. The event highlighted a new collaboration between pharmaceutical companies, industry regulators, and pharmacy organizations aimed at accelerating the reclassification of prescription medicines to over-the-counter (OTC) status, thus improving patient access to treatments. The event underscored the transformative impact of reclassification on patient autonomy, allowing for more convenient access to effective medicines and enhancing self-care practices across the UK.